MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
5.39
+0.19
+3.65%
After Hours: 5.45 +0.06 +1.11% 19:14 12/05 EST
OPEN
5.40
PREV CLOSE
5.20
HIGH
5.79
LOW
5.32
VOLUME
1.81M
TURNOVER
--
52 WEEK HIGH
5.79
52 WEEK LOW
3.809
MARKET CAP
318.53M
P/E (TTM)
-3.7653
1D
5D
1M
3M
1Y
5Y
1D
Market-Moving News for December 5th
Benzinga · 1d ago
FDA Removes Partial Clinical Hold On Tradipitant For Motion Sickness
NASDAQ · 1d ago
Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed
NASDAQ · 1d ago
Vanda jumps as FDA lifts tradipitant partial clinical hold
Seeking Alpha · 1d ago
FDA Lifts Hold on Vanda Pharmaceuticals' Motion Sickness Drug
Dow Jones · 1d ago
BUZZ-Vanda Pharmaceuticals gains after FDA lifts partial clinical hold on motion sickness treatment
Reuters · 1d ago
FDA Lifts Hold on Vanda’s Tradipitant Trials
TipRanks · 1d ago
Vanda Pharma Announces FDA Has Lifted The Partial Hold On Tradipitant, Clearing Path For Expanded Motion-Sickness Studies Ahead Of Dec. 30 PDUFA Date
Benzinga · 1d ago
More
About VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.